PDE6B and retinitis pigmentosa 1: Importantly, while previous studies had shown a protective effect of PARP inhibition in different rapidly degenerating Pde6a and Pde6b mutants [16,20,34], our work expands the group of RP genotypes potentially amenable to PARP inhibition treatment to also include slowly degenerating Prph2 mutants.